All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GLP-1 and macro tracking: what the nutrition science actually says

Trae✨

TikTok creator

131.7K viewsWatch on TikTok→

Quick answer

GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies. Adequate dietary protein intake during GLP-1 treatment is clinically relevant for preserving lean muscle mass during caloric restriction, but does not reliably prevent medication-induced side effects. Patients experiencing persistent GLP-1 side effects should consult their prescribing provider about dose titration rather than relying solely on dietary modifications.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @strivewithtrae actually say?

Trae posted a meal-prep video claiming to have lost over 100 pounds in a year combining GLP-1 medication with high-protein eating. The core nutritional claim: a single meal totaling 100 grams of protein from a Canadian bacon egg-and-cheese bagel, Greek yogurt, hemp seeds, and a protein shake. The boldest medical claim came mid-video: "If you have the right nutrition, you're probably not going to deal with side effects." Trae also promoted a supplement called Bellywelly, describing it as combining electrolytes, collagen, probiotics, and fiber in one product.

To be fair, Trae repeatedly framed the side-effect claim as personal experience, not medical advice. That caveat matters. But 131,000 views means a lot of people are taking this as a roadmap, not just a personal story.

Does the science back this up?

The protein math is mostly solid, and the general strategy of prioritizing protein on GLP-1s has real clinical support. The side-effect claim, though, is where things get shaky.

GLP-1 receptor agonists like semaglutide cause nausea, vomiting, and gastroparesis-like symptoms through a direct mechanism: slowing gastric emptying and acting on brainstem receptors that regulate nausea (Nauck et al., 2021, Diabetes Care). That's not a nutrition deficiency problem. It's pharmacology. A 2023 trial published in Obesity found that dietary composition did not significantly predict nausea severity in semaglutide users, though high-fat meals did worsen symptoms in some patients. Eating high protein may help with satiety and muscle preservation, which is genuinely important. Davies et al. (2021, The Lancet) showed that GLP-1 users who maintained higher protein intake preserved more lean mass during weight loss. That's a real benefit. But calling it a side-effect prevention strategy oversimplifies the mechanism considerably.

What did they get wrong (or right)?

Let's split this honestly. Trae got several things right. High protein intake during GLP-1-assisted weight loss is well-supported. Targeting 100 grams of protein daily aligns with recommendations from obesity medicine specialists for people in a caloric deficit (Stokes et al., 2018, Nutrients). The food protein counts cited in the video are largely accurate, within normal variation for packaged foods.

What Trae got wrong, or at least overstated, is the side-effect claim. Saying "you're probably not going to deal with side effects" if your nutrition is right is not something the literature supports. GLP-1 side effects, especially nausea and constipation, are dose-dependent and highly individual. They are not reliably prevented by diet quality. Someone who follows this advice exactly and still gets nauseous may feel like they failed, when in reality they just responded to the drug the way a large percentage of clinical trial participants did.

The Bellywelly supplement plug deserves scrutiny too. There is no peer-reviewed evidence that a combination supplement product specifically mitigates GLP-1 side effects. Fiber and electrolytes individually have some support for GI comfort, but bundled supplement products are not evaluated by the FDA for efficacy.

What should you actually know?

If you're on a GLP-1 medication, protein intake genuinely matters. Rapid weight loss without adequate protein accelerates muscle loss, and GLP-1-induced appetite suppression makes hitting protein targets harder. Aiming for 1.2 to 1.6 grams of protein per kilogram of body weight per day is a reasonable clinical target supported by research (Morton et al., 2018, British Journal of Sports Medicine).

But GLP-1 side effects are not a nutrition problem you can think your way out of. Nausea affects roughly 40 to 44 percent of semaglutide users in clinical trials at therapeutic doses (Wilding et al., 2021, NEJM). If you experience significant side effects, that conversation belongs with your prescribing clinician, not a TikTok comment section. Dose titration, timing of injections, and meal timing relative to the injection day are all levers your provider can adjust. Eating more Greek yogurt is not a substitute for that conversation.

Trae's weight loss journey appears genuine and the motivation is clearly real. But medical claims made to 130,000 people carry weight even when framed personally.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 11 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 and macro tracking: what the nutrition science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 and macro tracking: what the nutrition science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies.

FormBlends verdict

GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies. Adequate dietary protein intake during GLP-1 treatment is clinically relevant for preserving lean muscle mass during caloric restriction, but does not reliably prevent medication-induced side effects. Patients experiencing persistent GLP-1 side effects should consult their prescribing provider about dose titration rather than relying solely on dietary modifications.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists reduce appetite and slow gastric emptying, which supports weight loss but also causes nausea and GI side effects through direct pharmacological mechanisms, not nutritional deficiencies. Adequate dietary protein intake during GLP-1 treatment is clinically relevant for preserving lean muscle mass during caloric restriction, but does not reliably prevent medication-induced side effects. Patients experiencing persistent GLP-1 side effects should consult their prescribing provider about dose titration rather than relying solely on dietary modifications.
  • In the STEP 1 trial (Wilding et al., 2021, NEJM), roughly 44 percent of semaglutide users experienced nausea regardless of dietary patterns, meaning nutrition alone does not reliably prevent GLP-1 side effects.
  • Davies et al. (2021, The Lancet) found that higher protein intake during GLP-1 treatment helped preserve lean muscle mass, which is a real and clinically meaningful benefit of Trae's dietary approach.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • In the STEP 1 trial (Wilding et al., 2021, NEJM), roughly 44 percent of semaglutide users experienced nausea regardless of dietary patterns, meaning nutrition alone does not reliably prevent GLP-1 side effects.
  • Davies et al. (2021, The Lancet) found that higher protein intake during GLP-1 treatment helped preserve lean muscle mass, which is a real and clinically meaningful benefit of Trae's dietary approach.
  • Targeting 100 grams of protein daily is consistent with obesity medicine protein guidance for people in a caloric deficit, particularly those losing weight rapidly (Stokes et al., 2018, Nutrients).
  • GLP-1 side effects are dose-dependent and managed clinically through titration schedules, injection timing, and meal timing relative to injection days, not through diet alone.
  • Combination supplement products like Bellywelly are not FDA-evaluated for efficacy and have no peer-reviewed trial data supporting their use specifically for GLP-1 side effect management.
  • Protein counts cited in the video are mostly consistent with USDA nutritional data and standard packaged product labels, making the meal-planning content largely reliable as a practical reference.
  • Anyone experiencing significant GLP-1 side effects should discuss dose titration with their prescribing provider rather than relying on dietary modifications as a primary intervention strategy.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Trae✨ · TikTok creator

131.7K views on this video

Happy New Year🫶🏻✨ This series is very special to me! Nutrition is key to success! Luckily I have a dietitian with Fridays that helps me with my macros! 2026 is your year! 🩵

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Trae✨, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.